1998
DOI: 10.1016/s0006-8993(98)00749-5
|View full text |Cite
|
Sign up to set email alerts
|

Immunocytochemical localization of the NMDA-R2A receptor subunit in the cat retina

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
13
0

Year Published

2000
2000
2015
2015

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 56 publications
3
13
0
Order By: Relevance
“…Second, in previous studies of synaptic glutamate receptor localization in the IPL (Hartveit et al, 1994;Pourcho, 1996,1999;Fletcher et al, 2000;Pourcho et al, 2001;Hack et al, 2002), the specific cellular identity of the immunopositive postsynaptic processes was not positively determined. NMDAR-immunopositive processes, therefore, may have belonged to amacrine cells, a subset of which receive synaptic inputs mediated by NMDARs (Dixon and Copenhagen, 1992;Goebel et al, 1998;Fletcher et al, 2000;Gründer et al, 2000). Here, retrograde labeling of RGCs by CTB provided a reliable marker of RGC process in the IPL (Figure 2), enabling receptor localization to be examined on identified RGC processes.…”
Section: Comparison With Previous Workmentioning
confidence: 86%
See 1 more Smart Citation
“…Second, in previous studies of synaptic glutamate receptor localization in the IPL (Hartveit et al, 1994;Pourcho, 1996,1999;Fletcher et al, 2000;Pourcho et al, 2001;Hack et al, 2002), the specific cellular identity of the immunopositive postsynaptic processes was not positively determined. NMDAR-immunopositive processes, therefore, may have belonged to amacrine cells, a subset of which receive synaptic inputs mediated by NMDARs (Dixon and Copenhagen, 1992;Goebel et al, 1998;Fletcher et al, 2000;Gründer et al, 2000). Here, retrograde labeling of RGCs by CTB provided a reliable marker of RGC process in the IPL (Figure 2), enabling receptor localization to be examined on identified RGC processes.…”
Section: Comparison With Previous Workmentioning
confidence: 86%
“…AB1557P) was raised in rabbit against an affinity-purified C-terminal fusion protein (amino acids 984-1104). This antibody has been characterized previously in rat and cat retina by Western blotting (recognizing a band at ~ 180 kD) and immunocytochemistry (Goebel et al, 1998;Gründer et al, 2000;Pourcho et al, 2001). Polyclonal anti-GluR2/3 (Cat.…”
Section: Primary Antibodiesmentioning
confidence: 99%
“…In the brain, NO has also been shown to modulate the activity of ␥-aminobutyric acid A (GABA A ) receptors (Zarri et al, 1994;Wexler et al, 1998) and NMDA receptors (Lei et al, 1992;Manzoni et al, 1992;Manzoni and Bockaert, 1993). In the mammalian retina, a subset of amacrine cells, displaced amacrine cells, and ganglion cells have been shown to express GABA A receptors (Hughes et al, 1989(Hughes et al, , 1991Brecha, 1991Brecha, , 1992Greferath et al, 1993;Grü nert and Hughes, 1993;Wä ssle et al, 1998) and NMDA receptors (Hartveit et al, 1994;Brandstä tter et al, 1998;Goebel et al, 1998). Thus, NO could influence both amacrine cells and ganglion cells.…”
Section: Amacrine and Ganglion Cellsmentioning
confidence: 99%
“…Implicated in these disorders, the N-methyl-D-aspartate subtype of glutamate receptor (NMDAR), 2 which contributes to ON and OFF light-evoked responses in retinal ganglion cells (RGC) (5), has also been linked to mitochondrial dysfunction and RGC death when hyperstimulated (6 -8). Both RGCs and a large population of NMDAR-expressing amacrine cells (9,10) are highly susceptible to cell death in the presence of elevated levels of glutamate (11,12), whereby excessive calcium perturbs the mitochondrial membrane potential (⌬⌿ m ) promoting both programmed and nonprogrammed cell death pathways (7,13). In particular, the C terminus of the NMDAR GluN2B subunit contains a motif with high affinity for the PSD-95/Discs-large/ ZO-1 homology (PDZ) scaffold protein PSD-95 (14) that is believed to couple PSD-95 to neuronal nitric oxide synthase (NOS), resulting in a pro-death decrease in CREB activity (15).…”
mentioning
confidence: 99%